Takeda To Sell Dry Eye Drug Surgical Patch To Novartis J&J For Up To $5.7 Bln

Takeda To Sell Dry Eye Drug, Surgical Patch To Novartis, J&J For Up To $5.7 Bln

NEW BRUNSWICK (dpa-AFX) - Takeda Pharmaceutical Company Limited (TKPYY.PK) said that it agreed to divest its dry eye drug Xiidra to Novartis AG (NVS) and its TachoSil, a surgical patch designed to...

More From BioPortfolio on "Takeda To Sell Dry Eye Drug, Surgical Patch To Novartis, J&J For Up To $5.7 Bln"